Industry Satellite Symposia Sessions

Genitourinary Tumours, Prostate

← Back to the Areas of Interest  

 

 

 

INVITATION

AstraZeneca – Mapping pathways for PARP inhibition in prostate cancer: practical considerations for clinical practice 

View the full invitation